Stock Research: Steris

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Steris

NYQ:STE IE00BFY8C754
42
  • Value
    23
  • Growth
    49
  • Safety
    Safety
    58
  • Combined
    25
  • Sentiment
    75
  • 360° View
    360° View
    42
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

STERIS Plc provides products and services focused on infection prevention. It operates in Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The company serves healthcare providers worldwide, medical device and pharmaceutical manufacturers globally, and biopharmaceutical and medical device research and manufacturing facilities. In the last fiscal year, the company had a market cap of $22,511 million, profits of $2,403 million, revenue of $5,460 million, and 17,787 employees.

more
Index
D.J. US Health Care
D.J. US Medical Equipment
S&P 500
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
23 22 29 43
Growth
49 76 87 67
Safety
Safety
58 26 15 41
Sentiment
75 40 63 87
360° View
360° View
42 28 53 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
47 65 78 90
Opinions Change
50 23 29 50
Pro Holdings
n/a 65 64 86
Market Pulse
36 21 42 24
Sentiment
75 40 63 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
23 22 29 43
Growth
49 76 87 67
Safety Safety
58 26 15 41
Combined
25 23 25 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
28 23 28 33
Price vs. Earnings (P/E)
19 41 42 36
Price vs. Book (P/B)
21 34 34 56
Dividend Yield
64 39 40 42
Value
23 22 29 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
48 45 55 56
Profit Growth
67 36 57 58
Capital Growth
19 89 62 51
Stock Returns
63 60 83 63
Growth
49 76 87 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
54 36 38 52
Refinancing
17 17 33 35
Liquidity
89 42 30 47
Safety Safety
58 26 15 41

Similar Stocks

Discover high‑ranked alternatives to Steris and broaden your portfolio horizons.

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

bioMerieux

PAR:BIM
Country: France
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Carl Zeiss Meditec

GER:AFX
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: